PTPRC and neoplasm: Additionally, we isolated tumors, prepared single‐cell suspension, and performed flow cytometry to detect IL‐4R+ tumor cells (CD45− CD11b− CD3− CD124+) and found that DABIL‐4 treatment significantly reduced the frequency of IL‐4R+ cells in tumors (Fig. S5B).